Table 5 Results of the EORTC QLQ-C30 and QLQ_BR in percent of all breast cancer patients undergoing adjuvant, neoadjuvant or palliative therapies. * Kruskal-Wallis-Test
From: The effects of the COVID-19 pandemic on psychological stress in breast cancer patients
Adjuvant therapy n = 26 | Neoadjuvant therapy n = 26 | Palliative therapy n = 30 | |||||
|---|---|---|---|---|---|---|---|
Median | Interquartile range | Median | Interquartile range | Median | Interquartile range | p-value* | |
Global health status/Quality of Life | 58.33 | 50.00–75.00 | 62.50 | 41.67–75.00 | 50.00 | 50.00–66.67 | 0.396 |
Physical functioning | 86.67 | 66.67–93.33 | 80.00 | 66.67–93.33 | 66.67 | 46.67–86.67 | 0.520 |
Role functioning | 83.33 | 66.67–100.00 | 66.67 | 33.33–100.00 | 66.67 | 33.33–66.67 | 0.035 |
Emotional functioning | 58.33 | 50.00–83.33 | 58.33 | 50.00–75.00 | 50.00 | 33.33–66.67 | 0.200 |
Cognitive functioning | 83.33 | 66.67–100.00 | 83.33 | 50.00–100.00 | 66.67 | 50.00–83.33 | 0.318 |
Social functioning | 66.67 | 50.00–100.00 | 66.67 | 50.00–66.67 | 33.33 | 16.67–66.67 | 0.044 |
Fatigue | 27.78 | 11.11–55.56 | 33.33 | 33.33–55.56 | 55.56 | 33.33–77.78 | 0.023 |
Nausea and vomiting | 0.00 | 0.00–0.00 | 0.00 | 0.00–16.67 | 0.00 | 0.00–16.67 | 0.179 |
Pain | 16.67 | 0.00–33.33 | 8.33 | 0.00–33.33 | 33.33 | 16.67–66.67 | 0.006 |
Dyspnoea | 0.00 | 0.00–33.33 | 0.00 | 0.00–33.33 | 33.33 | 0.00–66-67 | 0.840 |
Insomnia | 66.67 | 0.00–66.67 | 33.33 | 0.00–66.67 | 33.33 | 33.33–66.67 | 0.745 |
Appetite loss | 0.00 | 0.00–0.00 | 0.00 | 0.00–0.00 | 0.00 | 0.00–66.67 | 0.021 |
Constipation | 0.00 | 0.00–33.33 | 0.00 | 0.00–0.00 | 0.00 | 0.00–33.33 | 0.187 |
Diarrhoea | 0.00 | 0.00–0.00 | 0.00 | 0.00–33.33 | 0.00 | 0.00–0.00 | 0.355 |
Financial difficulties | 0.00 | 0.00–33.33 | 0.00 | 0.00–33.33 | 33.33 | 0.00–66.67 | 0.264 |
Body image | 66.67 | 54.17–87.50 | 75.00 | 58.33–91.67 | 62.50 | 41.67–75.00 | 0.167 |
Sexual functioning | 8.33 | 0.00–41.67 | 16.67 | 0.00–16.67 | 16.67 | 0.00–33.33 | 0.924 |
Sexual enjoyment | 66.67 | 50.00–100.00 | 50.00 | 16.67–66.67 | 66.67 | 33.33–100.00 | 0.378 |
Future perspective | 33.33 | 0.00–66.67 | 33.33 | 0.00–66.67 | 33.33 | 0.00–66.67 | 0.824 |
Systemic therapy side effects | 21.43 | 12.70–35.71 | 38.10 | 14.29–47.62 | 30.95 | 19.05–47.62 | 0.295 |
Breast symptoms | 8.33 | 0.00–25.00 | 0.00 | 0.00–16.67 | 4.17 | 0.00–25.00 | 0.398 |
Arm symptoms | 22.22 | 11.11–44.44 | 22.22 | 0.00–33.33 | 11.11 | 0.00–33.33 | 0.488 |
Upset by hair loss | 33.33 | 0.00–50.00 | 66.67 | 0.00–100.00 | 66.67 | 66.67–66.67 | 0.470 |